TargetMol

Ginsenoside F2

Product Code:
 
TAR-T3916
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T3916-1mL1 mL * 10 mM (in DMSO)£151.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3916-20mg20mg£175.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs). It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction.
CAS:
62025-49-4
Formula:
C42H72O13
Molecular Weight:
785.025
Pathway:
Metabolism; Apoptosis; Autophagy
Purity:
0.993
SMILES:
CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C
Target:
Apoptosis; Endogenous Metabolite; Autophagy

References

Siraj FM1, SathishKumar N, Kim YJ, Kim SY, Yang DC.Ginsenoside F2 possesses anti-obesity activity via binding with PPAR? and inhibiting adipocyte differentiation in the 3T3-L1 cell line.J Enzyme Inhib Med Chem. 2015 Feb;30(1):9-14. Shin HS1, Park SY, Hwang ES, et al.Ginsenoside F2 reduces hair loss by controlling apoptosis through the sterol regulatory element-binding protein cleavage activating protein and transforming growth factor-? pathways in a dihydrotestosterone-induced mouse model.Biol Pharm Bull. 2014;37(5):755-63.